Merck to Acquire Curon Biopharmaceutical’s CN201, Expanding Pipeline in B-Cell Associated Diseases

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, &nb...

August 12, 2024 | Monday | News
Ascendis Pharma’s YORVIPATH® Offers Continuous PTH Therapy, Meeting Critical Needs of Over 70,000 U.S. Hypoparathyroidism Patients

Hypoparathyroidism is a rare endocrine disease with multi-organ impacts affecting an estimated 70,000 to 90,000 people in the United States Ascendi...

August 12, 2024 | Monday | News
MSD Discontinues Phase 3 KeyVibe-008 Trial for Extensive-Stage Small Cell Lung Cancer

Merck (NYSE: MRK), known as MSD outside of the United States and Canada,  announced the discontinuation of the Phase 3 KeyVibe-008 trial based on th...

August 09, 2024 | Friday | News
Integrated DNA Technologies Launches Rapid Genes for Expedited Drug Discovery

To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA ...

August 08, 2024 | Thursday | News
Calibre Scientific Acquires Acefesa, a Provider of Laboratory Consumables and Equipment in Spain

Calibre Scientific is pleased to announce the acquisition of ACEFE, S.A.U. (“ACEFESA” or the “Company”), a Barcelona-ba...

August 07, 2024 | Wednesday | News
Kyowa Kirin International Partners with NewBridge Pharmaceuticals to Distribute Rare Disease Treatments in Middle East and North Africa

Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...

August 07, 2024 | Wednesday | News
Thermo Fisher Scientific's SeCore™ CDx HLA A Sequencing System Receives FDA Clearance as Companion Diagnostic for Adaptimmune’s TECELRA® TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science,  announced that its SeCore™ CDx HLA A Sequencing System has been granted 5...

August 07, 2024 | Wednesday | News
Daiichi Sankyo and MSD Expand Collaboration to Co-Develop and Co-Commercialize DLL3 T-Cell Engager MK-6070

Agreement builds on and complements Daiichi Sankyo and Merck’s shared commitment to develop novel medicines for patients with cancer Daiichi Sanky...

August 07, 2024 | Wednesday | News
Fifty 1 Labs and All-In-Extracts Announce Joint Venture for Innovative Testosterone-Boosting Supplement

Fifty 1 Labs, Inc. , a holding company that operates in the sports supplement, fitness equipment, and health and wellness industries, and All-In-Extracts...

August 06, 2024 | Tuesday | News
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovia...

August 05, 2024 | Monday | News
MilliporeSigma Acquires Mirus Bio for $600 Million, Enhancing Viral Vector Manufacturing Capabilities

Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...

August 02, 2024 | Friday | News
Ecolab Sells Global Surgical Solutions Business to Medline for $950 Million

Ecolab closed on the sale of its global surgical solutions business to Medline for total consideration of approximately $950 million in cash. With Ecolab...

August 02, 2024 | Friday | News
CooperCompanies Acquires obp Surgical for $100 Million, Expanding Surgical Device Portfolio

CooperCompanies announced that CooperSurgical has acquired obp Surgical, a U.S.-based medical device company with a suite of single-use cordless surgical...

August 02, 2024 | Friday | News
Thermo Fisher Scientific Introduces Novel Pre-Transplant Risk Assessment Assay

Thermo Fisher Scientific, the world leader in serving science, has introduced a new pre-transplant risk assessment assay via its CLIA laboratory in Fishe...

July 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close